'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

Summary
(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...
Description from Medpagetoday.
Who is covering this
-
'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment
(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...
Comments
Comments need JavaScript.